Monday, April 27, 2015 12:17:48 PM
And remember this is not a new ground breaking technology or breakthrough Biotech stock looking at explosive growth. It's a no nothing, unbranded and unknown consumer product in a crowded space with no differentiation and tiny margins with a relatively high COG. And 2 billion shares out on MRIB is a HUGE number for a company that makes $2,000 a month. It's absurd to even consider MRIB an ongoing concern.
And this Brazil thing is also absurd. I have yet to hear any explanation of why or how MRIB could sell in Brazil when they can't sell in their own backyard? How's that going to happen? If the product doesn't sell here it won't sell there. That's just fact.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM